Minimally Invasive Biopsy Technologies Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2027
Market Size – USD 1.08 Billion in 2019, Market Growth - CAGR of 17.6%,
Market Trends – High demand in cognitive analytical insights
We
provide detailed product mapping and investigation of various market scenarios.
Our expert analysts provide a thorough analysis and breakdown of the market
presence of key market leaders. We strive to stay updated with the recent
developments and follow the latest company news related to the industry players
operating in the global Minimally Invasive Biopsy Technologies market. This
helps us to comprehensively analyze the individual standing of the companies as
well as the competitive landscape. Our vendor landscape analysis offers a
complete study to help you gain the upper hand in the competition.
This
all-encompassing report on the global Minimally Invasive Biopsy Technologies
market comprises of an executive summary that briefly describes the overall
market, its drivers, restraints, prominent segments, and competitive landscape.
Each part of the executive summary is distinctly explained in the report
through individual chapters. The chapters comprise of precise calculations
demonstrated through charts and graphs.
For More Details
Get FREE Sample Pages of this Research Report@ https://www.emergenresearch.com/request-sample-form/75
Regional Analysis
The North American region holds the
largest spot in the growth of Minimally Invasive Biopsy Technologies market
with a share of approximately 52.6% in the year 2019 and is contemplated to
hold the same by the end of the decade due to constant growth of the
construction industry of Mexico, Canada, and the United States in the region.
Regional Scope: North America; Europe; Asia Pacific;
Central & South America; MEA
Key
players in the market include Chronix Biomedical, Biocept, Inc., F.
Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher
Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive
Biotechnologies, and Owlstone Medical Ltd., among others.
Get
Access to Full summary of this report @ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market
Technology
Outlook (Revenue: USD Billion; 2017-2027)
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented Lesion Assays
- Breath Biopsy
- Brush Biopsy
- Others
Therapeutic
Application Outlook (Revenue: USD Billion; 2017-2027)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Blood Cancer
- Non-oncology Applications
End-Use
Verticals Outlook (Revenue: USD Billion; 2017-2027)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Others
Comments
Post a Comment